<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01448954</url>
  </required_header>
  <id_info>
    <org_study_id>ADC3680-04</org_study_id>
    <nct_id>NCT01448954</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma</brief_title>
  <official_title>A Randomised, Placebo-Controlled, Double-Blind, Parallel Group Phase II Study to Assess the Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pulmagen Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pulmagen Therapeutics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to examine the safety, tolerability, pharmacokinetics and functional activity
      of ADC3680B administered once daily for 28 days in subjects with partly controlled atopic
      asthma.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the change in frequency and severity of adverse events as a measure of safety and tolerability</measure>
    <time_frame>Baseline to Day 35</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the change in incidence of routine haematology and biochemistry abnormalities as a measure of safety</measure>
    <time_frame>Baseline to Day 35</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the change in vital signs as a measure of safety</measure>
    <time_frame>Baseline to Day 35</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the change in Pulmonary function as a measure of safety and tolerability</measure>
    <time_frame>Baseline to Day 35</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of the change in asthma symptoms using the Asthma Control Questionnaire as a measure of safety and tolerability</measure>
    <time_frame>Baseline to Day 28</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determination of concentrations of ADC3680B in plasma</measure>
    <time_frame>Days 1-2 and Days 28-30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exploratory assessment of exhaled nitric oxide and selected markers of inflammation in blood</measure>
    <time_frame>Day 1 and Day 28</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Atopic Asthma</condition>
  <arm_group>
    <arm_group_label>ADC3680B oral</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo oral</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ADC3680B oral</intervention_name>
    <description>Once daily for 28 days</description>
    <arm_group_label>ADC3680B oral</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo oral</intervention_name>
    <description>Once daily for 28 days</description>
    <arm_group_label>Placebo oral</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Partially controlled mild-moderate atopic asthma

          -  Receiving inhaled corticosteroids

          -  Non-smoker or former smoker

          -  Males and females aged 18 to 55 years inclusive

          -  If female, must be of non-childbearing potential

        Exclusion Criteria:

          -  History of acute severe asthma attacks

          -  History of COPD

          -  Other serious respiratory or other medical condition which may interfere with the
             outcome of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Belfast</city>
        <zip>BT9 6AD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Manchester</city>
        <zip>M23 9QZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2011</study_first_submitted>
  <study_first_submitted_qc>October 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2011</study_first_posted>
  <last_update_submitted>February 17, 2012</last_update_submitted>
  <last_update_submitted_qc>February 17, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

